Alan Schuster

1.6k total citations
23 papers, 1.3k citations indexed

About

Alan Schuster is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Alan Schuster has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Molecular Biology. Recurrent topics in Alan Schuster's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Cardiac electrophysiology and arrhythmias (5 papers). Alan Schuster is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Cardiac electrophysiology and arrhythmias (5 papers). Alan Schuster collaborates with scholars based in United States, Germany and Belgium. Alan Schuster's co-authors include Charles Frost, Frank LaCreta, Yu Chen Barrett, Daisy B. Whigan, Mohammed Jemal, Sunil Nepal, Rogelio Mosqueda‐Garcia, Andrew Shenker, Jessie Wang and Wonkyung Byon and has published in prestigious journals such as Pharmaceutical Research, Clinical Pharmacology & Therapeutics and Clinical Pharmacokinetics.

In The Last Decade

Alan Schuster

23 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alan Schuster United States	14	763	430	146	108	97	23	1.3k
Janice Pursley United States	14	772 1.0×	481 1.1×	85 0.6×	55 0.5×	59 0.6×	25	1.1k
Nobuko Matsushima Japan	14	638 0.8×	348 0.8×	143 1.0×	68 0.6×	32 0.3×	24	1.0k
Nirmala Raghavan United States	12	684 0.9×	458 1.1×	104 0.7×	218 2.0×	47 0.5×	17	1.1k
Lyle A. Siddoway United States	15	559 0.7×	141 0.3×	221 1.5×	161 1.5×	52 0.5×	25	1.1k
Willy Roth Germany	17	1.4k 1.8×	870 2.0×	205 1.4×	286 2.6×	158 1.6×	23	2.3k
Kurt‐Jürgen Hoffmann Sweden	16	219 0.3×	171 0.4×	187 1.3×	256 2.4×	180 1.9×	31	1.0k
Stefan Blech Germany	6	450 0.6×	289 0.7×	120 0.8×	81 0.8×	31 0.3×	8	771
Dietmar Ganßer Germany	19	1.0k 1.4×	727 1.7×	291 2.0×	147 1.4×	12 0.1×	30	1.9k
Eva Ludwig-Schwellinger Germany	8	479 0.6×	300 0.7×	251 1.7×	311 2.9×	69 0.7×	9	1.3k
Atef Halabi Germany	25	805 1.1×	335 0.8×	505 3.5×	142 1.3×	32 0.3×	79	2.2k

Countries citing papers authored by Alan Schuster

Since Specialization

Citations

This map shows the geographic impact of Alan Schuster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Schuster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Schuster more than expected).

Fields of papers citing papers by Alan Schuster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Schuster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Schuster. The network helps show where Alan Schuster may publish in the future.

Co-authorship network of co-authors of Alan Schuster

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Schuster. A scholar is included among the top collaborators of Alan Schuster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Schuster. Alan Schuster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Byon, Wonkyung, Sunil Nepal, Alan Schuster, Andrew Shenker, & Charles Frost. (2018). Regional Gastrointestinal Absorption of Apixaban in Healthy Subjects. The Journal of Clinical Pharmacology. 58(7). 965–971. 36 indexed citations

Frost, Charles, Yan Song, Zhigang Yu, et al.. (2017). The effect of apixaban on the pharmacokinetics of digoxin and atenolol in healthy subjects. Clinical Pharmacology Advances and Applications. Volume 9. 19–28. 13 indexed citations

Frost, Charles, Yan Song, Andrew Shenker, et al.. (2015). Effects of Age and Sex on the Single-Dose Pharmacokinetics and Pharmacodynamics of Apixaban. Clinical Pharmacokinetics. 54(6). 651–662. 75 indexed citations

Yuan, Long, et al.. (2015). Dried blood spot analysis without dilution: Application to the LC–MS/MS determination of BMS-986001 in rat dried blood spot. Journal of Chromatography B. 1002. 201–209. 5 indexed citations

Pursley, Janice, Jim X Shen, Alan Schuster, et al.. (2014). LC–MS/MS Determination of Apixaban (BMS-562247) and its Major Metabolite in Human Plasma: an Application of Polarity Switching and Monolithic HPLC Column. Bioanalysis. 6(15). 2071–2082. 47 indexed citations

Frost, Charles, Sunil Nepal, Jessie Wang, et al.. (2013). Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factorXa inhibitor, in healthy subjects. British Journal of Clinical Pharmacology. 76(5). 776–786. 225 indexed citations

Frost, Charles, Cui Yi-min, Yan Song, et al.. (2013). Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects. Clinical Pharmacology Advances and Applications. 5. 177–177. 32 indexed citations

Gu, Huidong, et al.. (2013). Development of a validated liquid chromatography tandem mass spectrometry assay for a PEGylated adnectin in cynomolgus monkey plasma using protein precipitation and trypsin digestion. Journal of Chromatography B. 934. 1–7. 15 indexed citations

Schuster, Alan, et al.. (2012). Application of a design of experiment approach in the development of a sensitive bioanalytical assay in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 70. 401–407. 8 indexed citations

10.

Zhang, Donglu, Kan He, Nirmala Raghavan, et al.. (2009). Comparative Metabolism of 14C-Labeled Apixaban in Mice, Rats, Rabbits, Dogs, and Humans. Drug Metabolism and Disposition. 37(8). 1738–1748. 89 indexed citations

11.

Badawy, Sherif I.F., David B. Gray, Fang Zhao, et al.. (2006). Formulation of Solid Dosage Forms to Overcome Gastric pH Interaction of the Factor Xa Inhibitor, BMS-561389. Pharmaceutical Research. 23(5). 989–996. 49 indexed citations

12.

Schuster, Alan, et al.. (2003). Quantitative determination of the HIV protease inhibitor atazanavir (BMS-232632) in human plasma by liquid chromatography–tandem mass spectrometry following automated solid-phase extraction. Journal of Chromatography B. 788(2). 377–386. 37 indexed citations

13.

Jemal, Mohammed, Alan Schuster, & Daisy B. Whigan. (2003). Liquid chromatography/tandem mass spectrometry methods for quantitation of mevalonic acid in human plasma and urine: method validation, demonstration of using a surrogate analyte, and demonstration of unacceptable matrix effect in spite of use of a stable isotope analog internal standard. Rapid Communications in Mass Spectrometry. 17(15). 1723–1734. 161 indexed citations

14.

Jemal, Mohammed, et al.. (2000). Liquid chromatography/electrospray tandem mass spectrometry method for the quantitation of fosinoprilat in human serum using automated 96-well solid-phase extraction for sample preparation. Rapid Communications in Mass Spectrometry. 14(12). 1023–1028. 23 indexed citations

15.

Piliero, Peter J., et al.. (2000). A preliminary pharmacokinetic and pharmacodynamic evaluation of the HIV protease inhibitor BMS-232632 in a protease inhibitor-naive HIV+ population. 4. 19. 6 indexed citations

16.

Srinivas, Nuggehally R., et al.. (1998). High-performance liquid chromatographic–electrochemical assay for the quantitation of BMS-181885 in monkey plasma. Journal of Chromatography B Biomedical Sciences and Applications. 705(2). 317–322. 1 indexed citations

17.

Srinivas, Nuggehally R., Wen Chyi Shyu, Carol Gleason, et al.. (1997). Effects of age, gender, and diurnal variation on the steady-state pharmacokinetics of BMS-181101, an antidepressant, in healthy subjects. Clinical Pharmacology & Therapeutics. 62(4). 408–416. 6 indexed citations

18.

Schuster, Alan, et al.. (1996). High-Performance Liquid Chromatographic - Ultraviolet Assay for the Simultaneous Quantitation of BMS-181101 and its Putative Hydroxy Metabolites in Rat and Monkey Plasma. Biomedical Chromatography. 10(3). 135–138. 2 indexed citations

19.

Shyu, Wen Chyi, et al.. (1996). Effects of Age, Gender and Diurnal Variation on the Steady-State Pharmacokinetics (PK) of BMS-181101. Clinical Pharmacology & Therapeutics. 59(2). 202–202. 2 indexed citations

20.

Whigan, Daisy B. & Alan Schuster. (1995). Manual and automated determination of and its metabolite (E)-5-(2-bromovinyl)uracil in urine. Journal of Chromatography B Biomedical Sciences and Applications. 664(2). 357–363. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact